Padmakumar Nair
Co-Founder & CEO · Ennoventure Inc.
Co-founder and CEO of Ennoventure, the anti-counterfeiting company he started in 2018 after learning at MIT that counterfeit anti-malarial medication was killing children in Africa. Its patented invisible signature embeds a cryptographic layer into existing product packaging without changing production lines, letting a shopper verify authenticity with a phone camera. The company is headquartered in Massachusetts with operations in India and Dubai.
Last reviewed: Sep 18, 2026
Padmakumar Nair
Co-Founder & CEO Ennoventure Inc.
Last Reviewed: September 18, 2026
Executive Summary
Padmakumar Nair is the co-founder and Chief Executive Officer of Ennoventure, an anti-counterfeiting and brand protection company he established in 2018 with Shalini Nair. The company’s approach is unusual in a crowded field: rather than adding holograms, QR codes, RFID tags, or any other physical element to a package, Ennoventure embeds a patented invisible cryptographic signature into the existing artwork, requiring no change to the production line and adding no unit cost. A consumer verifies the product by photographing the package with an ordinary phone. Nair’s stated motivation is closer to public health than to brand revenue: he founded the company after learning at MIT that counterfeit anti-malarial medication was killing children who had access to what they believed was treatment.
Career Highlights
- Co-founded Ennoventure in 2018 with Shalini Nair and leads it as CEO.
- Developed a patented invisible signature technology combining AI and cryptography, embedded into packaging with no change to production lines.
- Built the company across three markets, headquartered in Massachusetts with operations in India and Dubai.
- Accepted into the Forbes Business Council.
- Brings more than 18 years of global strategy and leadership experience across dispersed, multi-disciplinary teams.
- Alumnus of the MIT Sloan School of Management.
Professional Journey
Nair’s account of the company’s origin begins at MIT Sloan, where a classmate told him that a child in Africa was dying roughly every five minutes from malaria — a disease that is curable, and where the deaths in question were caused not by lack of access to medicine but by counterfeit anti-malarial drugs that contained no effective ingredient. The framing stayed with him because it inverted the usual understanding of counterfeiting as a problem of lost brand revenue. In pharmaceuticals, a convincing fake is not a commercial nuisance; it is lethal, and it is lethal specifically because it is convincing.
Existing anti-counterfeiting measures, he concluded, were poorly matched to the problem. Holograms, security inks, QR codes, and RFID tags all work by adding something physical to the package, which means added cost, changes to production lines, and a new artifact that can itself be copied. For high-volume, low-margin goods — including the medicines most likely to be faked in the markets where faking does the most harm — that overhead is often prohibitive.
In 2017 he approached Shalini Nair, then running her own business, and together they founded Ennoventure in 2018. Their technology takes a different route: an encrypted signature generated using artificial intelligence and cryptography is embedded invisibly within the packaging artwork itself. Nothing is added to the package, nothing changes on the production line, and nothing about the product’s appearance differs. Verification happens through a smartphone camera, which means the check can be performed by anyone in the supply chain, including the end consumer, without special equipment.
Ennoventure has grown into a global SaaS business headquartered in Massachusetts with operations in India and Dubai, serving brand owners seeking to protect both their products and the people who use them. Nair has been accepted into the Forbes Business Council and speaks regularly on digital transformation and brand trust.
Education
MIT Sloan School of Management
Alumnus
